Retraction

A novel AKR1C3 specific prodrug TH3424 with potent anti-tumor activity in liver cancer

Paper Information

Record ID:
40097
Publication Date:
October 25, 2019
Retraction Date:
December 04, 2019 (6.0 years years ago)
Article Type:
Publisher:
American Society for Clinical Pharmacology and Therapeutics
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1002/cpt.1708
Additional Notes:

Appears to be retract and replace. Initially published Oct 2019, withdrawn December 2019, published again July 2021 with notice of previous withdrawal (GS)

Citations (2)

2
Total Citations
1
Post-Retraction
(50.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
1 After 2+ years
1556 Days since retraction (latest)
Paper citing A novel AKR1C3 specific prodrug TH3424 with potent...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing A novel AKR1C3 specific prodrug TH3424 with potent...
Unknown Authors
Unknown Journal
Published: Mar 2024
1556 days after retraction
Quick Stats
Total Citations: 2
Years Since Retraction: 6.0 years
Open Access: Yes
Last Checked: Never
Related Papers
The immune system in hepatocellular carcinoma and potential…
BioMed Research International • 24 citations